JP2019526537A5 - - Google Patents

Download PDF

Info

Publication number
JP2019526537A5
JP2019526537A5 JP2019503703A JP2019503703A JP2019526537A5 JP 2019526537 A5 JP2019526537 A5 JP 2019526537A5 JP 2019503703 A JP2019503703 A JP 2019503703A JP 2019503703 A JP2019503703 A JP 2019503703A JP 2019526537 A5 JP2019526537 A5 JP 2019526537A5
Authority
JP
Japan
Prior art keywords
human insulin
zinc complex
acylated derivative
group
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019503703A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019526537A (ja
JP7432361B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2017/095377 external-priority patent/WO2018024186A1/zh
Publication of JP2019526537A publication Critical patent/JP2019526537A/ja
Publication of JP2019526537A5 publication Critical patent/JP2019526537A5/ja
Priority to JP2022066071A priority Critical patent/JP2022095872A/ja
Application granted granted Critical
Publication of JP7432361B2 publication Critical patent/JP7432361B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019503703A 2016-08-02 2017-08-01 ヒトインスリンまたはそのアナログのアシル化誘導体 Active JP7432361B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022066071A JP2022095872A (ja) 2016-08-02 2022-04-13 ヒトインスリンまたはそのアナログのアシル化誘導体

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN201610625257 2016-08-02
CN201610625257.5 2016-08-02
CN201610779132 2016-08-31
CN201610779132.8 2016-08-31
PCT/CN2017/095377 WO2018024186A1 (zh) 2016-08-02 2017-08-01 一种人胰岛素或其类似物的酰化衍生物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022066071A Division JP2022095872A (ja) 2016-08-02 2022-04-13 ヒトインスリンまたはそのアナログのアシル化誘導体

Publications (3)

Publication Number Publication Date
JP2019526537A JP2019526537A (ja) 2019-09-19
JP2019526537A5 true JP2019526537A5 (cg-RX-API-DMAC7.html) 2020-07-02
JP7432361B2 JP7432361B2 (ja) 2024-02-16

Family

ID=61074099

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019503703A Active JP7432361B2 (ja) 2016-08-02 2017-08-01 ヒトインスリンまたはそのアナログのアシル化誘導体
JP2022066071A Pending JP2022095872A (ja) 2016-08-02 2022-04-13 ヒトインスリンまたはそのアナログのアシル化誘導体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022066071A Pending JP2022095872A (ja) 2016-08-02 2022-04-13 ヒトインスリンまたはそのアナログのアシル化誘導体

Country Status (6)

Country Link
US (1) US10815287B2 (cg-RX-API-DMAC7.html)
EP (1) EP3495384A4 (cg-RX-API-DMAC7.html)
JP (2) JP7432361B2 (cg-RX-API-DMAC7.html)
CN (2) CN114478747B (cg-RX-API-DMAC7.html)
TW (1) TWI747929B (cg-RX-API-DMAC7.html)
WO (1) WO2018024186A1 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210040171A1 (en) * 2018-02-01 2021-02-11 Jiangsu Hengrui Medicine Co., Ltd. Pharmaceutical composition comprising acylated derivative of human insulin analog and preparation method thereof
CA3086618A1 (en) 2018-02-09 2019-08-15 Jiangsu Hengrul Medicine Co., Ltd. Codon optimized precursor gene and signal peptide gene of human insulin analogue
CA3100869A1 (en) 2018-05-24 2019-11-28 Jiangsu Hengrui Medicine Co., Ltd. Method for preparing precursor of recombinant human insulin or analogue thereof
EP3893934B1 (en) 2018-12-11 2025-09-10 Sanofi Insulin conjugates
CN118666989A (zh) 2019-12-30 2024-09-20 甘李药业股份有限公司 胰岛素衍生物
TW202229324A (zh) * 2020-11-27 2022-08-01 大陸商江蘇恒瑞醫藥股份有限公司 製備胰島素或其類似物的醯化衍生物的方法
CN112939771A (zh) * 2021-01-28 2021-06-11 宁夏蓝博思化学技术有限公司 长链烷基二酸单叔丁酯的制备方法
WO2022247773A1 (en) * 2021-05-24 2022-12-01 Sunshine Lake Pharma Co., Ltd. A novel acylated insulin analog
WO2022268208A1 (zh) 2021-06-25 2022-12-29 甘李药业股份有限公司 含酰化胰岛素的药物组合物
WO2023143458A1 (zh) 2022-01-28 2023-08-03 甘李药业股份有限公司 酰化胰岛素
CN117756914B (zh) * 2023-12-15 2024-09-03 瀚晖制药有限公司 依柯胰岛素的制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH25772A (en) * 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation
PT792290E (pt) 1993-09-17 2002-01-30 Novo Nordisk As Insulina acilada
CN1163574A (zh) * 1994-11-17 1997-10-29 伊莱利利公司 酰化的胰岛素类似物
US6310038B1 (en) * 1997-03-20 2001-10-30 Novo Nordisk A/S Pulmonary insulin crystals
WO2003075950A1 (en) * 2002-03-13 2003-09-18 Novo Nordisk A/S Minimising body weight gain in insulin treatment
BRPI0413276B8 (pt) 2003-08-05 2021-05-25 Novo Nordisk As derivado de insulina, complexo de zinco do mesmo, e, composição farmacêutica
EP2287184A3 (en) 2003-08-05 2011-08-10 Novo Nordisk A/S Novel insulin derivatives
DK1969004T3 (da) * 2005-12-28 2011-11-28 Novo Nordisk As Insulinsammensætninger og metode til at lave en sammensætning
EP2178910B1 (en) 2007-08-15 2014-10-08 Novo Nordisk A/S Insulins with an acyl moiety comprising repeating units of alkylene glycol containing amino acids
DK2910570T3 (en) * 2008-03-18 2017-01-30 Novo Nordisk As Protease-stabilized acylated insulin analogues.
US8935928B2 (en) * 2011-10-10 2015-01-20 Lockheed Martin Corporation Integrated air-cycle refrigeration and power generation system
CA2858253A1 (en) * 2011-12-15 2013-06-20 Shanghai Hengrui Pharmaceutical Co., Ltd. Human insulin analogue and acylated derivative thereof
CN106496322A (zh) * 2015-09-07 2017-03-15 江苏恒瑞医药股份有限公司 人胰岛素或其类似物的酰化衍生物的制备方法
CA3013623A1 (en) * 2016-02-05 2017-08-10 Memorial Sloan-Ketering Cancer Center Methods of differentiating stem cell-derived ectodermal lineage precursors

Similar Documents

Publication Publication Date Title
JP2019526537A5 (cg-RX-API-DMAC7.html)
JP2022095872A5 (cg-RX-API-DMAC7.html)
JP2012512901A5 (cg-RX-API-DMAC7.html)
JP2011006428A5 (cg-RX-API-DMAC7.html)
RU99106518A (ru) Glp-1 производные
RU2008143668A (ru) Производное инсулина
WO2019117274A1 (ja) ペプチドの製造方法、及び塩基の処理方法
WO2011080102A3 (en) Glp-1 analogues and derivatives
JP2013526501A5 (cg-RX-API-DMAC7.html)
JP2015110654A5 (cg-RX-API-DMAC7.html)
RU2009122582A (ru) Пэг-модифицированный эксендин или аналог эксендина и его композиции и применение
JP2007523881A5 (cg-RX-API-DMAC7.html)
EP3495384A1 (en) Acylated derivative of human insulin or analogue thereof
KR970042553A (ko) 캠프토테신 유도체
CA3084688A1 (fr) Solution injectable a ph 7 comprenant au moins une insuline basale dont le pi est compris entre 5,8 et 8,5 et un co-polyaminoacide porteur de charges carboxylates et de radicaux hydrophobes
NZ599791A (en) Therapeutic peptides
RU2019109719A (ru) Конъюгаты полимиксин-альгинатных олигомеров
JP2017508741A5 (cg-RX-API-DMAC7.html)
JP2009532384A5 (cg-RX-API-DMAC7.html)
JP5982562B2 (ja) ペプチドの塩酸塩及び他のペプチドとの併用によるその免疫治療用途
RU2020108281A (ru) Новые ацилированные аналоги инсулина и варианты их применения
RU2019109728A (ru) Конъюгаты бацитрацин-альгинатный олигомер
EP3740227A1 (fr) Compositions sous forme d'une solution aqueuse injectable comprenant de l'amyline, un agoniste au recepteur de l'amyline ou un analogue d'amyline et un co-polyaminoacide
JP2014530882A5 (cg-RX-API-DMAC7.html)
JP2013516424A (ja) シクロスポリン類似体